Literature DB >> 9196538

N-methyl-D-aspartate receptors, nitric oxide, and ethanol tolerance.

G S Morato1, J M Khanna.   

Abstract

Several experimental models have been used to study tolerance to ethanol. The development of tolerance to the motor incoordinating effect of a single administration of ethanol occurs within 8-24 h after the effect of the first dose has disappeared. This form of tolerance is designated rapid tolerance and seems to involve functional rather than pharmacokinetic mechanisms. Like chronic tolerance, rapid tolerance has been shown to be influenced by processes related to learning and memory. It is known that N-methyl-D-aspartate (NMDA) receptor systems are involved in the expression and maintenance of one form of long-term potentiation (LTP), a synaptic adaptive process which has been suggested to be the cellular basis of memory or associative memory. Considering the similarities between learning and tolerance, the effects of NMDA agonists and antagonists on tolerance to ethanol were investigated. Our studies demonstrated that NMDA antagonists that impair learning, such as dizocilpine or ketamine, inhibit tolerance, while NMDA agonists that improve learning, such as D-cycloserine, increase tolerance. Moreover, the nitric oxide synthase inhibitor L-nitroarginine blocks tolerance to the effects of ethanol. Taken together, these data confirm the involvement of the NMDA system in ethanol tolerance and emphasize the participation of learning in this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9196538

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  2 in total

1.  Rapid tolerance development to the NREM sleep promoting effect of alcohol.

Authors:  Rishi Sharma; Pradeep Sahota; Mahesh M Thakkar
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

Review 2.  Tolerance to alcohol: A critical yet understudied factor in alcohol addiction.

Authors:  Sophie K Elvig; M Adrienne McGinn; Caroline Smith; Michael A Arends; George F Koob; Leandro F Vendruscolo
Journal:  Pharmacol Biochem Behav       Date:  2021-02-23       Impact factor: 3.533

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.